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Few physiological parameters are more tightly and acutely regulated in humans than blood glucose
concentration. Themajor cellular mechanism that diminishes blood glucose when carbohydrates are
ingested is insulin-stimulated glucose transport into skeletal muscle. Skeletal muscle both stores
glucose as glycogen and oxidizes it to produce energy following the transport step. The principal glu-
cose transporter protein that mediates this uptake is GLUT4, which plays a key role in regulating
whole body glucose homeostasis. This review focuses on recent advances on the biology of GLUT4.Elevated glucose levels are rapidly returned to normal
(5–6 mM) even after huge caloric ingestions, and they
are maintained at only slightly lower levels during long-
term starvation. Such control prevents severe dysfunc-
tions such as loss of consciousness due to hypoglycemia
and toxicity to peripheral tissues in response to the
chronic hyperglycemia of diabetes. The major cellular
mechanism for disposal of an exogenous glucose load is
insulin-stimulated glucose transport into skeletal muscle.
Skeletal muscle both stores glucose as glycogen and ox-
idizes it to produce energy following the transport step.
The principal glucose transporter protein that mediates
this uptake is one isoform (Gene name, SLC2A4; protein
name: GLUT4) of a family of sugar transporter proteins
containing 12-transmembrane domains (Figure 1). The
GLUT4 glucose transporter is thus a major mediator of
glucose removal from the circulation and a key regulator
of whole-body glucose homeostasis. Here, we discuss
the known molecular and cellular regulatory mechanisms
for GLUT4, its gene regulation, its trafficking pathways
and their integration with insulin signaling, and the pro-
found effects GLUT4 exerts on whole-body metabolism.
GLUT4 is one of 13 sugar transporter proteins (GLUT1-
GLUT12, and HMIT) encoded in the human genome (Joost
and Thorens, 2001; Wood and Trayhurn, 2003) that cata-
lyzes hexose transport across cell membranes through
an ATP-independent, facilitative diffusion mechanism
(Hruz and Mueckler, 2001). These sugar transporters dis-
play differences in their kinetics and respective substrate
specificities, such that GLUT5 and perhaps GLUT11 are
likely fructose transporters. GLUT4 is highly expressed
in adipose tissue and skeletal muscle, but these tissues
also express a selective cohort of these other trans-
porters. In the case of skeletal muscle, GLUT1, GLUT5,
and GLUT12 may significantly contribute to sugar uptake
in addition to GLUT4 (Stuart et al., 2000, 2006), while in ad-
ipose tissue GLUT8, GLUT12, and HMIT are also ex-
pressed (Wood et al., 2003; Wood and Trayhurn, 2003).
However, GLUT4 displays the unique characteristic of a
mostly intracellular disposition in the unstimulated state
that is acutely redistributed to the plasma membrane in
response to insulin and other stimuli (Bryant et al., 2002;
Czech and Corvera, 1999).GLUT4 contains unique sequences in its N- and COOH-
terminal cytoplasmic domains that direct its characteristic
membrane trafficking capability (Figure 1). These include
a distinctive N-terminal sequence with a potentially critical
phenylalanine residue (Piper et al., 1993; Araki et al., 1996;
Melvin et al., 1999; Al-Hasani et al., 2002), as well as dileu-
cine and acidic motifs in the COOH terminus (Corvera et al.,
1994; Garippa et al., 1996; Shewan et al., 2000; Sandoval
et al., 2000; Martinez-Arca et al., 2000). These motifs likely
govern kinetic aspects of both endocytosis and exocyto-
sis in a continuously recycling trafficking system. The
COOH terminus LL and acidic motifs are also present in
an aminopeptidase protein (IRAP) that in adipocytes is
similarly sequestered within GLUT4-enriched intracellular
membranes and highly responsive to insulin action
(Johnson et al., 1998, 2001; Hou et al., 2006). These
considerations place GLUT4 at the interface of two excit-
ing fields of biology—insulin signaling and membrane
trafficking.
GLUT4 Is a Key Determinant of Glucose
Homeostasis
A central role for GLUT4 in whole-body metabolism is
strongly supported by a variety of genetically engineered
mouse models where expression of the transporter is ei-
ther enhanced or ablated in muscle or adipose tissue or
both. The whole-body GLUT4/ mouse itself may be less
informative due to upregulation of compensatory mecha-
nisms that may promote survival of these animals (Katz
et al., 1995; Stenbit et al., 1996). However, heterozygous
GLUT4+/ mice that display decreased GLUT4 protein in
muscle and adipose tissue show the expected insulin re-
sistance and propensity toward diabetes that is consistent
with a major role of GLUT4 in glucose disposal (Rossetti
et al., 1997; Stenbit et al., 1997; Li et al., 2000). Interest-
ingly, overexpression of GLUT4 expression in skeletal
muscle of such GLUT4+/ animals through crosses with
transgenic mice normalizes insulin sensitivity and glucose
tolerance (Tsao et al., 1999). Transgenic mice expressing
high levels of GLUT4 in adipose tissue (Shepherd et al.,
1993; Tozzo et al., 1995) or in skeletal muscle (Tsao
et al., 1996, 2001) in turn are both highly insulin sensitive
and glucose tolerant.Cell Metabolism 5, April 2007 ª2007 Elsevier Inc. 237
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ReviewFigure 1. Structural Features of the Insulin-Regulated GLUT4 Glucose Transporter Protein
The unique sensitivity of GLUT4 to insulin-mediated translocation appears to derive from sequences shown in the N-terminal (required phenylalanine)
and COOH-terminal (required dileucine and acidic residues) regions. These sequences are likely involved in rapid internalization and sorting of GLUT4
in intracellular membranes termed GLUT4 storage vesicles (GSV), as outlined in Figure 3. See text for further details.Conversely, conditional depletion of GLUT4 in either ad-
ipose tissue or skeletal muscle causes insulin resistance
and a roughly equivalent incidence of diabetic animals
(Zisman et al., 2000; Abel et al., 2001). This was particu-
larly surprising in the former case since adipose tissue
accounts for only a small fraction of total body glucose
disposal (James et al., 1985). These tissue-specific deple-
tions of GLUT4 have profound metabolic effects on other
tissues. For example, mice with muscle-specific GLUT4
deficiency display decreased insulin responsiveness in
adipose tissue and liver (Zisman et al., 2000), while those
with adipose-specific GLUT4 depletion exhibit muscle
and liver insulin resistance (Abel et al., 2001). In the mus-
cle-specific GLUT4 knockout mice, this is at least partially
mediated through elevated blood glucose levels that oc-
cur in the conditional knockout animals, which secondarily
impairs insulin signaling (Kim et al., 2001). Remarkably,
overexpression of GLUT4 in the adipose tissue of mus-
cle-specific GLUT4 deficient mice overcomes the glucose
intolerance and diabetes (Carvalho et al., 2005). More re-
cently, it has been reported that a retinol binding protein
(RBP4) is released into the serum from GLUT4-deficient
adipose tissue (Yang et al., 2005), and that RBP4 may
contribute to the insulin resistance of obese and diabetic
individuals (Graham et al., 2006). The mechanisms by
which glucose sensing through GLUT4 may operate to
integrate whole-body metabolism have been recently
reviewed (Herman and Kahn, 2006).
Even though cell surface GLUT4 is highly dependent on
insulin in vitro, muscle-specific (MIRKO) or adipose-
specific (FIRKO) insulin receptor knockout mice produce
surprisingly mild metabolic phenotypes compared to the238 Cell Metabolism 5, April 2007 ª2007 Elsevier Inc.conditional GLUT4 knockout mice described above.
MIRKO mice have an enlarged fat mass with increased se-
rum triglyceride and free fatty acids, but otherwise have
normal whole-body glucose homeostasis (Bruning et al.,
1998). Insulin-stimulated glucose uptake is greatly re-
duced in MIRKO muscle, but muscle glycogen level is nor-
mal, indicating possible compensatory mechanisms for
glucose import (Kim and Accili, 2002; Fernandez et al.,
2001). FIRKO mice have severe insulin resistance in
adipose tissue but are protected from age- and hyperpha-
gia-induced glucose intolerance (Bluher et al., 2002). This
favorable metabolic phenotype probably results from en-
hanced adiponectin and leptin secretion and improved
whole-body lipid metabolism (Xue and Kahn, 2006).
Thus, GLUT4 in muscle and adipose tissue is indispens-
able for normal global glucose homeostasis, while insulin
receptor in these tissues appears much less critical.
Analysis of the above mouse models also highlights the
potential dissociation between glucose uptake versus
triglyceride synthesis and storage in the adipocyte. The
adipose-specific GLUT4 deficient mouse has normal fat
mass and adipocyte size (Bluher et al., 2002). In the ab-
sence of robust glucose import and glycolysis, triglyceride
synthesis in adipocytes can proceed via enhanced glycer-
oneogenesis based on substrates derived from liver and
muscle (Reshef et al., 2003). On the other hand, lack of
the lipogenic and antilipolytic actions of insulin in adipo-
cytes of the FIRKO mouse leads to reduced fat mass.
These observations are consistent with the concept that
adipocytes are the major site for energy (triglyceride) stor-
age but not glucose disposal, which mostly occurs in mus-
cle. If this is the case, why did GLUT4-mediated glucose
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mechanism for maintaining whole-body glucose homeo-
stasis? Perhaps the answer to this question is that insu-
lin-regulated GLUT4 content on the adipocyte plasma
membrane closely reflects nutrient status and is therefore
a sensitive and reliable energy sensor.
Control of Endogenous GLUT4 Expression
The profound effects on whole-body glucose homeosta-
sis observed in mouse models of GLUT4 deficiency or
overexpression heighten the potential physiological im-
portance of changes in endogenous GLUT4 expression
in different states. Examples of particular interest are the
downregulation of GLUT4 expression in adipose tissue
in obesity (Olefsky et al., 1988; Garvey et al., 1991; Sinha
et al., 1991) and the upregulation of GLUT4 expression in
skeletal muscle in response to exercise (Ren et al., 1994;
Kraniou et al., 2000; Holmes and Dohm, 2004) or thyroid
hormone (Weinstein et al., 1991; Torrance et al., 1997a,
1997b). Also, GLUT4 expression is greatly decreased in
muscle atrophy (Didyk et al., 1994; Blakemore et al.,
1996) and denervation (Block et al., 1991; Henriksen
et al., 1991; Coderre et al., 1992), consistent with de-
creased energy requirements in these conditions. Signals
from neuronal cells in the form of neuregulins may mediate
some of these effects (Jo et al., 1995; Suarez et al., 2001).
These changes in GLUT4 protein levels could translate
into alterations in glucose tolerance if the effects observed
in transgenic mice apply to normal physiology. Thus, ther-
apeutic strategies based on enhancing GLUT4 expression
may facilitate drug discovery. For these reasons the
mechanisms that regulate GLUT4 expression are impor-
tant to clarify, and there is much fertile territory for explo-
ration in this field.
Tissue-specific expression of GLUT4 in adipose tissue,
skeletal muscle, and cardiac muscle, as well as its regula-
tion by fasting and refeeding, is conferred within a 2.4 kb
DNA segment at the 50 region of the GLUT4 gene (Liu
et al., 1992). For skeletal muscle-specific expression, a re-
gion between 522 and 420 has been inferred to be im-
portant in transgenic mice (Thai et al., 1998). This region
contains an apparent myocyte enhancer factor (MEF)2
binding domain at 466 to 457 that is critical for speci-
fying tissue expression (Liu et al., 1994) and increased
GLUT4 expression during muscle regeneration (Moreno
et al., 2003). Near this same region it has been proposed
that thyroid hormone receptor and myoD form a complex
with MEF2 to regulate GLUT4 expression (Santalucia
et al., 2001). However, modulation of GLUT4 expression
by denervation does not apparently require this region
(Tsunoda et al., 2000). Another domain that has been im-
plicated in tissue-specific expression is termed Domain I
and includes the region 742 to 712 relative to the initi-
ation site for transcription (Oshel et al., 2000). A factor
termed GEF appears to operate in this region in associa-
tion with MEF2A (Knight et al., 2003), but the putative
50kd GEF is identical in sequence to a segment of a larger
protein (HDBP1) that regulates the transcription of the
Huntington polypeptide in brain (Tanaka et al., 2004).These and other data have been recently reviewed in de-
tail (Olson and Knight, 2003; Zorzano et al., 2005), and
suggest a complex mode of GLUT4 regulation at the tran-
scriptional level that is poorly understood at present. Fur-
thermore, whether there are mechanisms that selectively
regulate translation or degradation of GLUT4 protein or
mRNA is unknown.
Signaling Mechanisms that Acutely
Regulate GLUT4
Both insulin and exercise acutely stimulate GLUT4 recruit-
ment to the cell surfaces of muscle and adipose cells inde-
pendent of transcription or translation (Herman and Kahn,
2006; Rose and Richter, 2005). Nevertheless, these two
physiological stimuli initiate distinct signaling mechanisms
that lead to enhanced GLUT4 translocation and glucose
uptake (Figure 2). The insulin signaling pathway to
GLUT4 has been discussed in detail in recent reviews
(Bryant et al., 2002; Watson et al., 2004a; Thong et al.,
2005). The canonical insulin signaling pathway is triggered
by activation of the insulin receptor (IR) tyrosine kinase
leading to tyrosine phoshphorylation of insulin receptor
substrate proteins (IRS) and their recruitment of PI 3-ki-
nase, which catalyzes conversion of phosphatidylinositol
(4,5)P2 to phosphatidylinositol (3,4,5)P3 (denoted PIP3).
PIP3 in turn triggers the activation of the protein kinase
Akt through the actions of two intermediate protein ki-
nases, PDK1 and Rictor/mTOR (Vanhaesebroeck and
Alessi, 2000; Sarbassov et al., 2005b). The requirements
of these overall reactions have largely been confirmed in
vivo using genetically engineered mouse models (Nandi
et al., 2004; Plum et al., 2005), and more recently by siRNA
knockdown experiments in cultured cells (Jiang et al.,
2003; Mitra et al., 2004; Zhou et al., 2004; Tang et al.,
2005). Interestingly, Akt2 rather than the Akt1 or Akt3 iso-
forms appears to control GLUT4 trafficking in adipose and
muscle cells as well as mediate insulin signaling to control
glucose output in liver (Cho et al., 2001a; Bae et al., 2003;
Jiang et al., 2003), while the Akt1 isoform appears to con-
trol cell and body size (Cho et al., 2001b; Whiteman et al.,
2002) and Akt3 controls brain size (Easton et al., 2005).
Substrates of Akt2 that may mediate insulin effects on
the machinery of GLUT4 trafficking are being actively in-
vestigated. The GTPase activating protein TBC1D4, de-
noted AS160, is such a substrate (Kane et al., 2002) that
catalyzes inactivation of Rab proteins 2A, 8A, 10 and 14
in vitro. Rab proteins are critical organizers of intracellular
membrane trafficking (Zerial and McBride, 2001). Expres-
sion of mutant AS160 lacking Akt-specific phosphoryla-
tion sites inhibits insulin-stimulated GLUT4 translocation
(Sano et al., 2003), suggesting it is a negative regulator
that is itself inhibited by insulin through Akt. AS160 binding
to IRAP has been demonstrated, although there are con-
tradictory claims regarding whether such interaction is
modulated by Akt phosphorylation of AS160 (Larance
et al., 2005; Peck et al., 2006). It is also noteworthy that
AS160 interaction with 14-3-3 proteins is dependent on
Akt phosphorylation of its Thr642 residue (Ramm et al.,
2006). AS160 plays a role in insulin-stimulated GLUT4Cell Metabolism 5, April 2007 ª2007 Elsevier Inc. 239
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Pathways Initiated by Insulin and
Exercise Leading to GLUT4
Translocation
Insulin signaling through the PI 3-kinase path-
way and muscle contraction through both ele-
vated AMP/ATP ratios and intracellular [Ca2+]
leads to activation of downstream protein ki-
nases (Akt, aPKCl/z, AMPK, CaMKII cPKC)
that phosphorylate putative effectors that
modulate steps in the GLUT4 trafficking path-
ways (also see Figure 3). AS160 is one such
substrate that appears to negatively regulate
an early step in GLUT4 exocytosis. Negative
regulation of these pathways by fatty acids,
cytokines, and endoplasmic reticulum stress
responses are observed in obesity and diabe-
tes, contributing to insulin resistance. Dashed
lines imply hypothetical pathways not yet
experimentally verified. See text for further
details.exocytosis but not its inhibition of GLUT4 endocytosis
(Zeigerer et al., 2004). RNAi knockdown of AS160 in-
creases basal GLUT4 levels on the adipocyte surface,
consistent with its proposed role in intracellular GLUT4 re-
tention that is relieved upon insulin stimulation (Eguez
et al., 2005; Larance et al., 2005). However, AS160 knock-
down only partially releases the pool of intracellular
GLUT4 mobilized by insulin, and careful analysis suggests
that other unknown Akt substrate proteins must make ma-
jor contributions to overall GLUT4 regulation by insulin
(Eguez et al., 2005; Gonzalez and McGraw, 2006, Bai
et al., 2007).
Muscle contraction also increases AS160 phosphoryla-
tion, but it may do so by a PI 3-kinase independent mech-
anism (Bruss et al., 2005; Kramer et al., 2006; Deshmukh
et al., 2006). Contraction-induced AS160 phosphorylation
is mediated through the AMPK pathway, providing a po-
tential convergence of insulin and exercise-mediate sig-
naling to GLUT4 (see Figure 2; Jessen and Goodyear,
2005; Kramer et al., 2006; Treebak et al., 2006). On the
other hand, simultaneously disrupting AMPK and Akt
failed to completely inhibit contraction-induced AS160
phosphorylation, consistent with additional signals lead-
ing to GLUT4 translocation (Figure 2). Interestingly, cal-
modulin binds to AS160 in a Ca2+-dependent manner
(Kane and Lienhard, 2005), and treatment of T cells with
calcium ionophore increases AS160 mRNA levels (Matsu-
moto et al., 2004). Furthermore, it appears that AS160 is
a target of metabolic disease related to insulin resistance.
Insulin-stimulated AS160 phosphorylation is impaired in
skeletal muscle of type II diabetic patients (Karlsson
et al., 2005) and in response to TNF-a (Plomgaard et al.,
2005). Furthermore, in skeletal muscle of first-degree rel-
atives of diabetic patients, the correlation between
AS160 phosphorylation and glucose uptake is lost, pre-
dicting an increasing risk for onset of the disease (Karlsson240 Cell Metabolism 5, April 2007 ª2007 Elsevier Inc.et al., 2006). However, levels of insulin-induced GLUT4
translocation in the skeletal muscle of type II diabetic pa-
tients are typically reduced by 90% (Ryder et al., 2000),
while the correspondent impairment in AS160 phosphory-
lation is down only 39% (Karlsson et al., 2005). Thus,
other components of the GLUT4 translocation machinery
are most likely also impaired in diabetic patients, and it is
not yet clear whether defective AS160 phosphorylation
contributes functionally to insulin resistance.
Substantial evidence also indicates atypical PKCl/z
acts downstream of PI 3-kinase to relay insulin signals to
GLUT4 translocation (Farese et al., 2005; Figure 2). How-
ever, there are conflicting results using RNAi regarding the
importance of PKCl/z on insulin-stimulated glucose up-
take in adipocytes (Zhou et al., 2004; Sajan et al., 2006).
Thus, the precise roles of atypical PKCl/z in GLUT4 regu-
lation need further clarification, perhaps from tissue-spe-
cific knockout mice. A proposed PI 3-kinase-independent
pathway including component proteins APS, c-Cbl, CAP,
CrkII/C3G, and TC10 has also been proposed to operate
in parallel to the PI 3-kinase pathway as a required mech-
anism that promotes GLUT4 translocation (Saltiel and
Kahn, 2001; Saltiel and Pessin, 2003). Indeed, good evi-
dence indicates that APS and CAP proteins do associate
with insulin receptor complexes (Ribon et al., 1998; Hu
et al., 2003). However, siRNA-mediated gene silencing
of several intermediates of this putative signaling pathway
in 3T3-L1 adipocytes have challenged this hypothesis (Mi-
tra et al., 2004; Zhou et al., 2004), and other data suggest
TC10 does not promote GLUT4 translocation in cultured
muscle cells (JeBailey et al., 2004). Furthermore, gene ab-
lation of APS or c-Cbl in mice actually improve insulin sen-
sitivity in peripheral tissues, consistent with the idea that
these proteins act instead as negative regulators of the in-
sulin signaling pathway (Minami et al., 2003; Molero et al.,
2004). Thus, APS may be involved in insulin receptor
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et al., 2006; Katsanakis and Pillay, 2005). Perhaps TC10
functions in control of actin which secondarily facilitates
GLUT4 movements in 3T3-L1 adipocytes (Chiang et al.,
2001; Kanzaki et al., 2002; Chang et al., 2006), but whether
this occurs in primary adipocytes is unknown. The fact
that ectopic expression in adipocytes of an activated
form of Akt alone stimulates GLUT4 translocation is con-
sistent with the concept that the PI 3-kinase pathway
may be sufficient for GLUT4 translocation (Kohn et al.,
1996; Eyster et al., 2005). However, expressed Akt could
have confounding effects in such experiments and further
data are required to unequivocally clarify this point.
The PI 3-kinase pathway mediates insulin signaling to
regulate GLUT4 in skeletal muscle as well (Ploug and Ral-
ston, 2002; Ishiki and Klip, 2005). In addition, muscle con-
traction acutely increases GLUT4 transporter levels in sar-
colemma and T-tubules, and is additive to the effect of
insulin stimulation (Nesher et al., 1985; Zorzano et al.,
1986). Muscle contraction and insulin stimulation were
suggested to target separate pools of intracellular
GLUT4-containing membranes, and convincing evidence
has established that these processes are regulated by dif-
ferent signaling mechanisms (see recent reviews by Hol-
loszy, 2003; Jessen and Goodyear, 2005; Rose and
Richter, 2005). Two cellular consequences of muscle con-
traction, a transient increase in intracellular calcium con-
centration ([Ca2+]i) and an increase in [AMP]/[ATP] ratio,
are thought to contribute to enhanced GLUT4 transloca-
tion to the cell surface (Figure 2). The former signal is me-
diated through activations of the protein kinase CaMKII
and perhaps conventional protein kinase C (Jessen and
Goodyear, 2005; Rose and Richter, 2005). In addition,
Ca2+/CaM appears to activate the AMPK signaling path-
way through upstream kinases CaMKKa and b, at least
in cultured cell lines and ex vivo brain slices (Hurley
et al., 2005; Hawley et al., 2005; Woods et al., 2005).
AMPK acts as a cellular energy gauge that is allosterically
activated by increasing [AMP]/[ATP] ratios and perhaps
other mechanisms. This transforms AMPK into a better
substrate for at least one of its upstream activator kinases,
e.g., LKB1, or a potentially poorer substrate for one of its
phosphatases (reviewed by Fujii et al., 2006; Jorgensen
et al., 2006). Muscle glycogen appears to be potent nega-
tive regulator of AMPK activity (Derave et al., 2000; Woj-
taszewski et al., 2002), thus providing a negative feedback
mechanism for AMPK-mediated glucose uptake. The crit-
ical substrates (‘‘effectors’’ in Figure 2) that mediate
GLUT4 translocation downstream of these protein kinases
are unknown.
The role of AMPK in contraction-induced glucose up-
take has been questioned. Muscle-specific overexpres-
sion of a dominant-inhibitory catalytic subunit of AMPK
(i.e., a2-AMPK: the major catalytic isoform in skeletal mus-
cle) reduced contraction-mediated glucose uptake by
only 30%–40% (Mu et al., 2001). However, a recent report
suggests even that modest effect can be accounted for by
a corresponding decrease in force generation by the
transgenic muscle (Fujii et al., 2005). On the other hand,examinations of skeletal muscle isolated from whole-
body a1-AMPK or a2-AMPK knock-out mice suggest
that in the absence of the a2 subunit, the a1 catalytic do-
main may mediate contraction-induced glucose uptake
(Jorgensen et al., 2004). Furthermore, muscle-specific
deletion of LKB1 (the major upstream AMPK kinase in
muscle) inhibits contraction-induced glucose uptake,
which cannot be explained by reduction in muscle force
generation (Sakamoto et al., 2005). However, since LKB1
also phosphorylates and activates many other AMPK-
related kinases (Lizcano et al., 2004), AMPK involvement
is unclear. Interestingly, muscle-specific LKB1 knockout
mice have enhanced insulin sensitivity and improved
whole-body glucose homeostasis (Koh et al., 2006), sug-
gesting AMPK also regulates the insulin signaling pathway
in vivo (Sarbassov et al., 2005a; Um et al., 2006). Never-
theless, enhanced muscle glucose uptake in response to
activation of AMPK by AICAR (i.e., an AMP analog) is not
additive to that achieved through muscle contraction, indi-
cating AMPK is a component of the contraction signaling
mechanism (Hayashi et al., 1998). As discussed above,
Ca2+/CaM-mediated signaling pathways also lead to
GLUT4 translocation (Figure 2). Recently, increases in
cytosolic Ca2+ were found to induce metalloproteinase-
mediated release of neuregulins, which activates receptor
tyrosine kinase ErbB4 (Canto et al., 2006). Importantly,
blocking ErbB4 activation impairs contraction-induced
glucose uptake in slow twitch muscle fibers where alterna-
tive AMPK signaling is minimal. In addition, muscle cell
depolarization increases surface GLUT4 through reduced
endocytosis independent of AMPK activity (Wijesekara
et al., 2006). Thus, existing evidence indicates an
AMPK-mediated pathway may be one of several redun-
dant contraction-induced signaling mechanisms leading
to GLUT4 translocation to the cell surface.
A variety of other cellular stress signals also enhance
glucose uptake in skeletal muscle. Hypoxia and inhibitors
of cellular metabolism (e.g., glycolysis inhibitor arsenate;
electron transport inhibitor rotenone; oxidative phosphor-
ylation uncoupler 2,4-dinitrophenol) signal at least partially
through AMPK by decreasing the cellular energy supply
and increasing AMP/ATP ratios (Figure 2). Hyperosmolal-
ity also promotes GLUT4 translocation by activating
AMPK in muscle or by activating a Gab-1 dependent sig-
naling pathway in adipocytes (Gual et al., 2003). Interest-
ingly, osmotic shock also activates PIKfyve, a recently
identified Akt substrate (Berwick et al., 2004; Sbrissa
and Shisheva, 2005). The lipid product of PIKfyve activity
[i.e., PtdIns(5)P] has been shown to promote GLUT4 exo-
cytosis to the adipocyte plasma membrane (Sbrissa et al.,
2004). Paradoxically, chronic hyperosmotic stress results
in insulin resistance in isolated or cultured adipocytes,
which is apparently mediated through the mTOR signaling
pathway (Gual et al., 2003). Recent breakthroughs in
mTOR signaling have revealed intricate negative feedback
mechanisms that target the insulin and AMPK signaling
pathways (reviewed by Sarbassov et al., 2005a; Um et al.,
2006). In addition, impaired responsiveness of GLUT4 to
the insulin signaling pathway occurs in obesity andCell Metabolism 5, April 2007 ª2007 Elsevier Inc. 241
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2004), cytokines (Kanda et al., 2006; Weisberg et al.,
2003), and the endoplasmic reticulum stress response
(Ozcan et al., 2006). These negative regulators appear to
act in part through the activation of stress protein kinases
that phosphorylate IRS proteins on serine residues, thus
attenuating the tyrosine phosphorylation of IRS by insulin
(see Figure 2). The detailed mechanisms through which in-
sulin resistance may be induced in obesity and diabetes
has been recently reviewed (Petersen and Shulman,
2006; Marciniak and Ron, 2006; Tilg and Moschen, 2006).
Regulated Steps in the Membrane Recycling
of GLUT4
Newly synthesized and glycosylated GLUT4 enters a con-
tinuously recycling pathway that concentrates most of the
GLUT4 in intracellular membrane systems in unstimulated
adipocytes or muscle cells (Cushman and Wardzala,
1980; Suzuki and Kono, 1980; Oka et al., 1984; for recent
reviews see Bryant et al., 2002; Dugani and Klip, 2005). In-
sulin markedly stimulates GLUT4 exocytic pathways (ar-
rows 1, 2, and 5 in Figure 3) while also significantly inhibit-
ing its endocytosis from the PM (arrow 4 in Figure 3), which
together cause the overall redistribution of GLUT4 to the
cell surface (Czech and Buxton, 1993; Holman and Cush-
man, 1994; Zeigerer et al., 2004). Recently, Blot and
McGraw, 2006 reported that endocytosis of GLUT4 in
unstimulated cells occurs mostly through a cholesterol-
dependent, clathrin adaptor AP-2-independent pathway,
while insulin selectively inhibits this. Thus, GLUT4 recycling
in insulin-stimulated adipocytes and muscle may be a spe-
cialized case of the clathrin-dependent recycling pathway
which occurs in all cells, best studied in reference to the
transferrin receptor (TfR) (for review, see Maxfield and
McGraw, 2004, and Figure 3). Iron-bound transferrin (Tf)
is taken up by TfR and endocytosed through a clathrin-
mediated mechanism in the plasma membrane (PM)
which requires the Rab5 GTPase. Newly endocytosed
vesicles merge with each other to form sorting endo-
somes/early endosomes (SE/EE) or are delivered directly
to existing SE/EE. Proteins or lipids can be rapidly recycled
back to the cell surface through narrow tubular structures
derived from SE/EE (thin blue dotted line in Figure 3). SE/
EE are transient structures that appear to gradually mature
into later endosomes (LE) to form lysosomes (LY). During
this process, ferric ions dissociate from Tf-TfR in the in-
creasingly acidic luminal environment, while the receptor
is sorted to the endosomal recycling compartment (ERC)
through tubular-vesicular structures. ERC is a stable cellu-
lar organelle, from which TfR escapes (thin blue solid line
in Figure 3) with a slower rate than its influx rate. In the
case of adipocytes, a highly insulin-responsive, special-
ized GLUT4 sequestration compartment (GSV) is thought
to be downstream of the ERC (Figure 3). Skeletal and heart
muscle have uniquely structured membrane systems
through which insulin-sensitive GLUT4 trafficking pro-
ceeds, but the mechanisms for stimulation of GLUT4
translocation to the cell surface may be very similar (for re-
views see Ploug and Ralston, 2002; Ishiki and Klip, 2005).242 Cell Metabolism 5, April 2007 ª2007 Elsevier Inc.The GSV membranes in adipocytes that selectively se-
quester GLUT4 and certain other proteins such as IRAP
can be experimentally distinguished from the ERC (Fig-
ure 3). This concept is derived from studies using horse-
radish peroxidase-conjugated transferrin (Tf-HRP) to ab-
late membrane compartments constituting the general
recycling pathway. Thus it was found that in unstimulated
cultured adipocytes, more than 50% of the intracellular
GLUT4 escapes Tf-HRP ablation, apparently by localizing
in specialized membranes (GSV) sensitive to insulin (Liv-
ingstone et al., 1996; Martin et al., 1997, 1998; Millar
et al., 1999; Zeigerer et al., 2002). The transition of endo-
cytosed GLUT4 from endosomes to GSVs can be moni-
tored by time-dependent Tf-HRF ablation, which is assis-
ted by Rab11 (Zeigerer et al., 2002) and requires the
sorting signal FQQI on the GLUT4 N terminus (Melvin
et al., 1999; Palacios et al., 2001; see Figure 1). Interest-
ingly, GLUT4 accumulates with TfR in ERC when exoge-
nously expressed in fibroblasts, and subsequent exodus
of both GLUT4 and TfR to the PM can be stimulated by in-
sulin (Lampson et al., 2000, 2001). Nevertheless, GLUT4 is
more effectively sequestered than TfR and responds more
strongly to insulin stimulation, due in part to the dileucine
sorting motif on the GLUT4 COOH terminus (Johnson
et al., 2001; arrow 2 in Figure 3). Furthermore, TfR and
GLUT4 are sorted into the ERC through different mecha-
nisms and subsequently escape in distinct secretory ves-
icles, indicating GLUT4 is uniquely sorted even in fibro-
blasts (Wei et al., 1998; Lampson et al., 2001). The fact
that ERC also likely contributes to insulin-enhanced glu-
cose uptake in adipose and muscle cells, as evidenced
by TfR sensitivity to insulin, suggest that GSVs could be
evolutionarily derived from recycling endosomes to confer
greater insulin sensitivities to these cells (Kandror and
Pilch, 1998; Hashiramoto and James, 2000; Lampson
et al., 2001; Becker et al., 2001; Zeigerer et al., 2002). It
should also be noted that the rapid recycling pathway di-
rectly from SE/EE to the PM (thin blue dotted line in Fig-
ure 3) defined for TfR recycling (Sheff et al., 2002; van
Dam et al., 2002) has not yet been tested for its potential
responsiveness to insulin (arrow 3 in Figure 3). Taken to-
gether, these and other data support the hypothesis pre-
sented in Figure 3 that insulin signaling directly modulates
the GSV (arrow 1) and to a lesser extent the ERC (arrow 2)
to promote translocation of GLUT4 and other recycling
proteins to the PM.
Multiple studies have established GSVs as major tar-
gets of insulin-mediated mobilization in insulin-sensitive
tissues (Aledo et al., 1997; Martin et al., 1998, 2000; Millar
et al., 1999; Hashiramoto and James, 2000). Furthermore,
recent evidence supports the concept that GLUT4 contin-
uously recycles through this compartment, albeit slowly in
the basal state, as opposed to being stored in a static site
that is not in equilibrium with the PM (see references for
contrasting views: Coster et al., 2004; Govers et al.,
2004; Karylowski et al., 2004; Martin et al., 2006). Bio-
chemically, GSVs lack common endosomal markers
such as TfR, Rab4, annexin II and cellubrevin (Aledo
et al., 1997; Hashiramoto and James, 2000), but are
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ReviewFigure 3. Combinatorial Regulation by
Insulin of Multiple Steps in the
Membrane Trafficking Pathways of
GLUT4
GLUT4 continuously recycles through several
membrane systems of adipose and muscle
cells and accumulates in sequestration vesi-
cles (GSV) and perhaps other intracellular
membranes (e.g., ERC, TGN) due to very slow
exocytosis rates in the absence of stimulation.
Insulin stimulates exocytosis of GSV (arrow 1)
and ERC (arrow 2) and may also enhance a
rapid short circuit pathway from the sorting en-
dosome/early endosome (SE/EE) to the plasma
membrane (PM) (dashed arrow 3). Recent data
indicate that insulin signaling also directly en-
hances the fusion of docked GLUT4-contain-
ing vesicles by decreasing docking duration
(arrow 5), and a preceding tethering step may
also be insulin regulated (dashed arrow 6). In
addition, insulin signaling attenuates GLUT4
endocytosis (arrow 4), which in combination
with its stimulatory effects on exocytic steps
promotes redistribution of GLUT4 to the cell
surface. Insulin-responsive Akt (see Figure 2)
may operate in the early steps of exocytosis
(arrows 1 and 2), while other PI 3-kinase-dependent mediators may operate at the fusion step (arrow 5), but further work is necessary to confirm
this hypothesis. Dashed arrows emanating from insulin indicate hypotheses that await definitive experimental approaches. Insulin may also regulate
the interchange (blue dashed bidirectional arrows) between membranes deriving from endosomal recycling compartment (ERC), the trans-Golgi
(TGN), and GSV (circle 7). All of the above membrane trafficking pathways are thought to be governed by small Rab GTPases or related proteins,
which have been reviewed in detail elsewhere (Zerial and McBride, 2001).Cell Metabolism 5, April 2007 ª2007 Elsevier Inc. 243enriched in GLUT4 (but not GLUT1), IRAP and the
v-SNARE protein VAMP2 (Martin et al., 1996). They are a
subpopulation of GLUT4-containing vesicles that can
be isolated based on lack of cellugyrin content and are
mostly sensitive to insulin mobilization (Kupriyanova et al.,
2002). There is also an ongoing dispute on whether the
TGN itself is the GSV compartment. The existence of ret-
rograde transport from endosomes to TGN that is utilized
by TGN proteins MPR, furin and TGN38 supports the TGN
hypothesis (Bonifacino and Rojas, 2006). Electron micros-
copy shows a sizable GLUT4 population is located in en-
dosomes and TGN (Slot et al., 1991; Martin et al., 1997).
Based on quantitative colocalization analysis between
GLUT4 and CD-MPR (cation-dependent manose-6-phos-
phate receptor) before and after insulin stimulation, it was
proposed that TGN interacts with recycling endosomes to
generate GSVs (Martin et al., 2000; Ramm et al., 2000;
Bryant et al., 2002). After passing through endosomal
compartments in the 3T3-L1 adipocyte, GLUT4 appar-
ently transits into perinuclear vesicular-tubular structures
that are partially labeled by endosome/TGN t-SNAREs
syntaxins 6 and 16 (Shewan et al., 2003). These syntaxins
appear to be important for transporting GLUT4 to GSVs,
and an acidic targeting motif near the dileucine on the
COOH terminus of GLUT4 is proposed to be the sorting
signal involved in this process (Shewan et al., 2003; Perera
et al., 2003; Proctor et al., 2006). On the other hand, endo-
cytosed GLUT4 localizes poorly with TGN38 and furin,
suggesting that TGN plays a minimal role in intracellular
GLUT4 recycling (Martin et al., 1994; Karylowski et al.,
2004).
These seemingly contradictory results could be due to
complexity in TGN organization (Gu et al., 2001; Gleesonet al., 2004), such that GLUT4 trafficking proceeds
through a subdomain of the TGN that is labeled by CD-
MPR, syntaxins 6 and 16, but not by TGN38 and furin. It
is also known that Golgi/TGN morphology and function
change dramatically depending on cell type and physio-
logical state (Polishchuk and Mironov, 2004). Thus, in
specialized adipocytes the boundary between TGN and
endosomes may be altered and a conventional TGN pro-
tein may perform a trafficking role outside the classical
TGN. For example, the SNARE protein Vti1a is involved
in vacuole-TGN trafficking in yeast but interacts with Syn-
taxins 6 and 16 in endosome-TGN trafficking in Hela cell
(von Mollard et al., 1997; Mallard et al., 2002). Vti1a is a
constitutive protein on GLUT4-containing membranes,
and colocalizes extensively with GLUT4 in perinuclear
structures in basal 3T3-L1 adipocytes (Bose et al.,
2005). However, Vti1a is completely segregated from
other Golgi/TGN proteins such as b-COP, p115 and
g-adaptin, and its intracellular localization is not disrupted
by the Golgi-specific drug brefeldin A. Instead Vti1a ap-
pears required for insulin-stimulated GLUT4 translocation
(Bose et al., 2005), a function that is consistent with
Vti1a-b localization in brain synaptic vesicles (Antonin
et al., 2000). Nonetheless, it appears that whatever the
nature of the insulin-sensitive GLUT4 sequestration com-
partment, it does not statically retain GLUT4 away from
a continuously recycling dynamic even in the basal state
(Martin et al., 2006).
Even though it is not clear if the TGN serves as an insu-
lin-sensitive sequestration compartment for GLUT4, the
TGN does appear to function in GLUT4 transit to the GSV
compartment (Figure 3). Golgi-localized g-ear-containing
Arf binding proteins (GGAs) are a family of adaptors for
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subpopulation of transport vesicles involved in TGN-en-
dosome trafficking. Importantly, GGA proteins apparently
function in effective sorting of newly synthesized GLUT4
and IRAP into GSVs in adipocytes, which occurs before
these molecules enter the GLUT4 recycling pathway (Fig-
ure 3; Watson et al., 2004b; Liu et al., 2005). Acquiring
GSVs is an important component of adipocyte differentia-
tion, and is assisted by sortilin, a resident membrane pro-
tein on GSVs (Morris et al., 1998; Shi and Kandror, 2005).
Furthermore, GGAs may also be involved in regenerating
GSVs following insulin stimulation (Li and Kandror,
2005). Cargo proteins recognized by GGAs have a dileu-
cine sorting motif on their cytoplasmic domains (Bonifa-
cino, 2004), consistent with the functional dileucine motif
in IRAP (Johnson et al., 1998; Hou et al., 2006) and
GLUT4 (Czech et al., 1993; Haney et al., 1995; Araki et al.,
1996; Melvin et al., 1999; Shewan et al., 2000; Sandoval
et al., 2000). Also, p115, a member of the Golgin family
of proteins associated with the Golgi, colocalizes with
GLUT4 in perinuclear structures through interaction with
the N terminus of IRAP (Hosaka et al., 2005). Overexpres-
sion of the p115 N terminus disperses GLUT4 perinuclear
localization and inhibits insulin-stimulated GLUT4 translo-
cation. More recently, Golgin-160 has been shown to
function at a step in the GLUT4 biosynthetic pathway prior
to GGA-dependent sorting into GSVs (Williams et al.,
2006).
The Eps15-homology (EH) domain containing proteins
are important components of the molecular machinery
regulating intracellular membrane sorting and trafficking
(Naslavsky and Caplan, 2005). Mammalian cells contain
a subset of these proteins with the EH-domain located
on the COOH terminus (EHD1-EHD4). EHD2 resides on
GLUT4-containing membranes in primary adipocytes
(Guilherme et al., 2004a), and EHD1 partially colocalizes
with GLUT4 in perinuclear structures of 3T3-L1 adipo-
cytes (Guilherme et al., 2004b). EHD2 functions in cla-
thrin-mediated Tf-TfR and GLUT4 endocytosis (Guilherme
et al., 2004a), while EHD1 is important for perinuclear se-
questration of GLUT4 and may also play a role in generat-
ing GSVs (Guilherme et al., 2004b). These effects are in
part mediated by EHBP1 (EH-domain binding protein 1),
which binds to actin bundles through its CH domain and
to EHD1/EHD2 through NPF motifs (Guilherme et al.,
2004b). Importantly, RNAi knockdown of EHBP1 com-
pletely inhibits insulin-stimulated GLUT4 translocation in
cultured adipocytes (Guilherme et al., 2004b), producing
an inhibitory phenotype that is stronger than Akt knock-
down in the same cells (Jiang et al., 2003). EHD1 is also re-
quired for exocytosis of major histocompartibility complex
I and cystic fibrosis transmembrane conductance regula-
tor (Caplan et al., 2002; Picciano et al., 2003). Interestingly,
EHD1 is shown to interact with the Rab11 effector Rab11-
FIP2 (Naslavsky et al., 2006), and Rab11 is known to func-
tion in GLUT4 exocytosis (Zeigerer et al., 2002; Uhlig et al.,
2005). Thus, EHD1, Rab11 and Rab11-FIP2 may coordi-
nate intracellular sorting and trafficking of endocytosed
GLUT4 in adipocytes.244 Cell Metabolism 5, April 2007 ª2007 Elsevier Inc.TIRF Imaging Applied to GLUT4 Recycling
The concept that insulin signaling causes recruitment of
GLUT4 to regions near the PM from the intracellular GSV
and ERC (Figure 3) has recently been supported by total
internal reflection fluorescence (TIRF) microscopy (Ten-
gholm and Meyer, 2002; Lizunov et al., 2005; Gonzalez
and McGraw, 2006; Bai et al., 2007, Huang et al., 2007).
This technique images a region of about 100-250nm
from the outside surface of the PM into the cytoplasm
(Steyer and Almers, 2001), and reveals that insulin stimu-
lates total GLUT4 levels in this region of the adipocyte
by 2- to 3-fold (Tengholm and Meyer, 2002; Gonzalez
and McGraw, 2006; Huang et al., 2007). This increased
GLUT4 in the TIRF zone includes GLUT4 fused into the
PM as well as GLUT4 in membrane vesicles underneath
or docked to the PM. High resolution TIRF microscopy
has now clearly consolidated the concept that insulin sig-
naling directly modulates the PM membrane fusion mech-
anism (arrow 5 in Figure 3) that completes GLUT4 exocy-
tosis in response to insulin (Huang et al., 2007, Bai et al.,
2007). The insulin-mediated fusion step (arrow 5 in Fig-
ure 3) and insulin-stimulated recruitment/docking steps
(arrows 1 and 2) are both dependent on PI 3-kinase activ-
ity. Akt inhibition greatly decreases GLUT4 in the TIRF
zone, reflecting its presumed role in mediating the recruit-
ment/docking of GLUT4 containing vesicles in response
to insulin (Gonzalez and McGraw, 2006).
Interestingly, there is continuing debate about the re-
quirement of Akt for the fusion step of GLUT4 trafficking
to the PM. The rate of membrane fusion of GLUT4-con-
taining vesicles relative to the amount of GLUT4 in the
TIRF zone appeared to be greater when Akt was inhibited
than when PI 3-kinase was inhibited in the study by Gon-
zalez and McGraw, 2006. However, these results are
based on the use of small molecule inhibitors and the
analysis must be further confirmed by additional experi-
ments. Indeed, reconstitution of GLUT4-containing vesi-
cle fusion to the PM in a cell free system does seem to re-
quire Akt (Koumanov et al., 2005). It should also be noted
that the mechanisms that may contribute to the increased
GLUT4 in the TIRF zone in response to insulin include
intracellular mobilization of GSVs (Bryant et al., 2002),
movements on microtubules (Semiz et al., 2003) or actin
(Tsakiridis et al., 1999; Kanzaki and Pessin, 2001; Jiang
et al., 2002), motor proteins (Bose et al., 2002; Imamura
et al., 2003), or even the formation of new GLUT4-contain-
ing membranes (Xu and Kandror, 2002). Another potential
mechanism for intracellular retention of GLUT4 is insulin-
sensitive tethering through TUG protein (Bogan et al.,
2003; Yu et al., 2007). These potential mechanisms all
require further investigation to rigorously define their
contributions to GLUT4 recruitment to the TIRF zone or
docking prior to the fusion step. A particularly appealing
approach to unraveling the mechanisms of GLUT4 recruit-
ment into the TIRF zone (arrows 1 and 2 in Figure 3) is to
identify additional putative Akt substrates that may medi-
ate these effects.
The mechanisms that regulate membrane fusion of
GLUT4 containing vesicles with the PM remain elusive.
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signaling and the sites for exocytic GLUT4 vesicle fusion
and clathrin-dependent and cholesterol-dependent GLUT4
endocytosis (Figure 3). The SNARE core proteins (i.e.,
VAMP2, syntaxin 4 and SNAP23) mediating exocytic
GLUT4 vesicle fusion with the PM have been well charac-
terized, and a few SNARE-associated proteins potentially
regulating SNARE core formation have been identified
(i.e., Munc18c, synip, tomosyn). These results are summa-
rized in recent reviews (Bryant et al., 2002; Watson et al.,
2004a; Ishiki and Klip, 2005; James, 2005). In addition,
the exocyst complex has been proposed to function in
exocytic GLUT4 vesicle tethering (Inoue et al., 2003,
2006; Ewart et al., 2005). Recently, a two-color TIRF mi-
croscope that is capable of imaging membrane trafficking
events at 10 frames per second (fps) and at a spatial res-
olution approaching the optical limitation (i.e., 259 nm at
488 nm laser excitation) has been used to image GLUT4
docking and fusion events (Huang et al., 2007). Novel
image-analysis tools have been developed to process
thousands of TIRF images obtained from a single experi-
ment (Huang et al., 2007). Analysis of hundreds of sin-
gle-vesicle fusion events showed that insulin stimulates
GLUT4 vesicle fusion frequency by 4 fold while signifi-
cantly shortening vesicle tethering/docking durations
prior to membrane fusion (arrow 5 in Figure 3). These con-
clusions have also been recently reported by Bai et al.,
2007 using a different type of TIRF-based analysis. Insulin
action is also associated with immobilization of GLUT4-
containing structures in the TIRF evanescence field (Lizu-
nov et al., 2005; Huang et al., 2007), which is largely due
to endocytic GLUT4 accumulation in static clathrin coats
on the PM (Bellve et al., 2006; Huang et al., 2007). Taken
together, the data available to date strongly support
multiple direct effects of insulin on the movement of
GLUT4 into proximity of the PM as well as direct effects
of insulin on one or more steps of the docking and fusion
process at the PM (Figure 3).
Conclusions
The role of GLUT4 as a dominant regulator of whole-body
glucose homeostasis is now well established, based on
many genetically engineered mouse models of GLUT4
overexpression or deficiency. These data reinforce the
concept that either acute or long-term changes in the
abundance of GLUT4 on the cell surface of adipose or
muscle cells could provoke systemic changes in glucose
disposal in vivo. Such changes include decreased
GLUT4 expression in adipocytes in obesity and increased
GLUT4 expression in adipocytes and muscle cells in re-
sponse to exercise. However, we are still at an early stage
of understanding the molecular mechanisms that underlie
GLUT4 expression in these tissues. Some transcription
factors involved in GLUT4 mRNA regulation are identified,
but their exact roles within the various physiological states
that alter GLUT4 expression need to be further clarified
within transgenic mouse models. Other transcriptional
regulators also likely play important roles and remain to
be discovered.Significant progress in understanding the membrane re-
cycling pathway of GLUT4 has been made, including the
identification of a RabGAP substrate (AS160) of the insu-
lin-sensitive protein kinase Akt that may help restrain
GLUT4 exocytosis in the basal state. Other unknown sub-
strates also likely play a role, and their identification is cru-
cial to further progress. Application of new imaging tech-
niques to GLUT4 recycling has also yielded important
new insights, including the hypothesis that both Akt-de-
pendent and Akt-independent steps downstream of PI
3-kinase may be involved. Importantly, it is now clear
that multiple steps in the GLUT4 trafficking pathway are
regulated by insulin, and that the overall response of
GLUT4 to insulin is combinatorial. For example, TIRF mi-
croscopy has demonstrated direct effects of insulin sig-
naling on both the movement of GLUT4 from intracellular
sites to distances within about 200nm of the PM as well
as on the kinetics of GLUT4-containing vesicle docking
and fusion. The ability to visualize GLUT4 recycling and
docking/fusion steps by such imaging technology reveals
the exciting complexity we face as each of the many traf-
ficking steps are dissected and analyzed in future studies.
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